Investment in women’s health has declined sharply since 2021, but venture companies expect start-ups with innovative solutions, especially in areas of high unmet need like menopause and endometriosis, will continue to attract funding.
According to SVB, now part of First Citizens Bank, venture funding in the US and Europe for women’s health rose from $111m in the first
However, it has cooled of late. Leerink Partners says venture funding in women’s and family health care peaked in 2021 at more than $2.5bn, fell to $1.7bn in 2022, and has dropped to $707m in 2023 as of October